# Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease

> **NCT01614574** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 6 (actual)

## Conditions studied

- Gaucher Disease

## Interventions

- **BIOLOGICAL:** velaglucerase alfa

## Key facts

- **NCT ID:** NCT01614574
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-02
- **Primary completion:** 2013-05-25
- **Final completion:** 2013-05-25
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2021-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01614574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01614574, "Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01614574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*